Fake Avastin contained several chemicals, no drug

February 28, 2012

(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

The Swiss drugmaker says an analysis of the contents of the vials picked up traces of 10 substances, ranging from starch and salt to chemicals like acetone, a solvent used in paint thinner.

Roche said it is unclear whether the substances would cause harmful effects in patients.

The is investigating the source of counterfeit imported and distributed by a U.S. wholesaler to doctors here. Authorities in Europe have traced the counterfeit product back through distributors in Britain, Denmark and Switzerland. The original country of origin is still unclear.

Explore further: Counterfeit toothpaste is discovered

shares

Related Stories

Counterfeit toothpaste is discovered

June 14, 2007

The U.S. Food and Drug Administration said a counterfeit toothpaste falsely packaged as "Colgate" has been found in four states.

FDA says breast cancer drug did not extend lives

July 16, 2010

(AP) -- Federal health scientists said Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential withdrawal in that indication.

FDA: Avastin should not be used for breast cancer (Update)

December 16, 2010

(AP) -- Federal health authorities are recommending the blockbuster drug Avastin no longer be used to treat breast cancer, saying recent studies failed to show the drug's original promise to help slow the disease.

Counterfeit drugs becoming big business worldwide

February 16, 2012

(AP) -- The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United States is raising new fears that the multibillion-dollar drug-counterfeiting trade is increasingly making ...

Recommended for you

Non-addictive painkiller shows promise in animal trials

August 30, 2016

(HealthDay)—Preliminary research in monkeys suggests that a new medication might be able to provide pain relief similar to opioid drugs such as OxyContin, but without the same potential for addiction or serious side effects.

Mylan launching cheaper, generic version of EpiPen

August 29, 2016

The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.